Pharma major Lupin Limited announced the launch of the United States Food and Drug Administration (FDA) approved leflunomide tablets USP, 10 mg and 20 mgThe product would be manufactured at Lupin’s Pithampur (Unit I) facility in India.Leflunomide tablets USP, 10 mg and 20 mg, is the generic equivalent of Aravat tablets, 10 mg and 20 mg, of Sanofi-Aventis US LLC., and is indicated for the treatment of adults with active rheumatoid arthritis (RA).Leflunomide tablets USP had an annual sales of approximately US$ 42 million in the US, according to IQVIA MAT June 2020.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!